There are no official guidelines to assist in answering this question. I will search for relevant research papers instead.
From the Research
Treatment Overview
- The treatment for Hand, Foot, and Mouth Disease (HFMD) in a 1-year-old patient is mainly symptomatic and supportive 1.
- There are no specific treatments and vaccines licensed for general use in the treatment of various serotypes of HFMD 2.
- Intravenous immunoglobulin should be considered for the treatment of severe/complicated hand, foot, and mouth disease 1.
Management Strategies
- Counseling and monitoring are an integral part in the management of HFMD 3.
- Active communication and close monitoring are required to manage HFMD without complications 3.
- Good personal hygiene and vaccination of susceptible individuals in high-risk areas are important preventative measures to combat the disease 1.
Pharmaceutical Interventions
- Oseltamivir, a neuraminidase inhibitor, has been used as an adjunctive therapy for the treatment of HFMD, and meta-analyses of randomized clinical trials have shown its effectiveness in reducing fever clearance time, rash regression time, and clinical cure time 4.
- An inactivated Enterovirus A71 (EV-A71) vaccine has been approved by the China Food and Drug Administration (CFDA) and has been shown to provide a high level of protection against EV-A71-related HFMD 5.